| Literature DB >> 25023086 |
Dipika Mohanty1, Ajit C Gorakshakar, Roshan B Colah, Ramesh Z Patel, Dilip C Master, J Mahanta, Santanu K Sharma, Utpal Chaudhari, Malay Ghosh, Sheila Das, Reitt P Britt, Shawinder Singh, Cecil Ross, Lata Jagannathan, Rajni Kaul, Deepak K Shukla, Vasantha Muthuswamy.
Abstract
Although iron deficiency anemia is very common in India, systematic large studies on the prevalence and hematological consequences of iron deficiency among carriers of β-thalassemia (β-thal) and other hemoglobinopathies are lacking. A multi center project was undertaken to screen college/university students and pregnant women for iron deficiency anemia and various hemoglobinopathies. Fifty-six thousand, seven hundred and seventy-two subjects from six states, Maharashtra, Gujarat, Karnataka, West Bengal, Assam and Punjab, were studied. Iron deficiency anemia was evaluated by measuring zinc protoporphyrin (ZPP) and hemoglobin (Hb) levels, while β-thal and other hemoglobinopathies were detected by measuring the red cell indices and by Hb analysis using high performance liquid chromatography (HPLC). College boys (2.2%), college girls (14.3%) and antenatal women (27.0%) without any hemoglobinopathies had iron deficiency anemia. Among the β-thal carriers, the prevalence of iron deficiency anemia was 17.3% in college boys, 38.1% in college girls and 55.9% in pregnant women, while in the Hb E [β26(B8)Glu→Lys; HBB: c.79G>A] carriers, it was 7.3% in college boys, 25.4% in college girls and 78.0% in antenatal women. In individuals with Hb E disease, the prevalence of iron deficiency anemia varied from 31.2-77.3% in the three groups. A significant reduction in Hb levels was seen when iron deficiency anemia was associated with hemoglobinopathies. However, the Hb A2 levels in β-thal carriers were not greatly reduced in the presence of iron deficiency anemia.Entities:
Keywords: India; college students; iron deficiency anemia; pregnant women; β-Thalassemia (β-thal)
Mesh:
Year: 2014 PMID: 25023086 DOI: 10.3109/03630269.2014.913517
Source DB: PubMed Journal: Hemoglobin ISSN: 0363-0269 Impact factor: 0.849